These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38759814)

  • 1. A spectrum of AKT3 activating mutations cause focal malformations of cortical development (FMCDs) in cortical organoids.
    Xu Y; Lu R; Li H; Feng W; Zhao R
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167232. PubMed ID: 38759814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development.
    Baek ST; Copeland B; Yun EJ; Kwon SK; Guemez-Gamboa A; Schaffer AE; Kim S; Kang HC; Song S; Mathern GW; Gleeson JG
    Nat Med; 2015 Dec; 21(12):1445-54. PubMed ID: 26523971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination.
    Park SM; Lim JS; Ramakrishina S; Kim SH; Kim WK; Lee J; Kang HC; Reiter JF; Kim DS; Kim HH; Lee JH
    Neuron; 2018 Jul; 99(1):83-97.e7. PubMed ID: 29937275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
    Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
    Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
    Lee JH; Huynh M; Silhavy JL; Kim S; Dixon-Salazar T; Heiberg A; Scott E; Bafna V; Hill KJ; Collazo A; Funari V; Russ C; Gabriel SB; Mathern GW; Gleeson JG
    Nat Genet; 2012 Jun; 44(8):941-5. PubMed ID: 22729223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
    Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
    Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene.
    Conti V; Pantaleo M; Barba C; Baroni G; Mei D; Buccoliero AM; Giglio S; Giordano F; Baek ST; Gleeson JG; Guerrini R
    Clin Genet; 2015 Sep; 88(3):241-7. PubMed ID: 25091978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
    D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
    Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
    Gerasimenko A; Baldassari S; Baulac S
    Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.
    Lee WS; Stephenson SEM; Howell KB; Pope K; Gillies G; Wray A; Maixner W; Mandelstam SA; Berkovic SF; Scheffer IE; MacGregor D; Harvey AS; Lockhart PJ; Leventer RJ
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1338-1344. PubMed ID: 31353856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
    Alcantara D; Timms AE; Gripp K; Baker L; Park K; Collins S; Cheng C; Stewart F; Mehta SG; Saggar A; Sztriha L; Zombor M; Caluseriu O; Mesterman R; Van Allen MI; Jacquinet A; Ygberg S; Bernstein JA; Wenger AM; Guturu H; Bejerano G; Gomez-Ospina N; Lehman A; Alfei E; Pantaleoni C; Conti V; Guerrini R; Moog U; Graham JM; Hevner R; Dobyns WB; O'Driscoll M; Mirzaa GM
    Brain; 2017 Oct; 140(10):2610-2622. PubMed ID: 28969385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR.
    Dobyns WB; Mirzaa GM
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):582-590. PubMed ID: 31441589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Leventer RJ; Scerri T; Marsh AP; Pope K; Gillies G; Maixner W; MacGregor D; Harvey AS; Delatycki MB; Amor DJ; Crino P; Bahlo M; Lockhart PJ
    Neurology; 2015 May; 84(20):2029-32. PubMed ID: 25878179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives.
    Mühlebner A; Bongaarts A; Sarnat HB; Scholl T; Aronica E
    J Anat; 2019 Sep; 235(3):521-542. PubMed ID: 30901081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR signaling in epilepsy: insights from malformations of cortical development.
    Crino PB
    Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.